For Four Days Starting from the 16th

On the 21st, Hugel announced that it had invited Taiwanese medical professionals to Korea to host the global academic program ‘L.E.A.D.: Letybo Experience & Discovery’.

Hugel invited Taiwanese medical professionals to Korea for four days starting from the 16th to hold the global academic program 'L.E.A.D.' Hugel

Hugel invited Taiwanese medical professionals to Korea for four days starting from the 16th to hold the global academic program 'L.E.A.D.' Hugel

View original image

From the 16th over four days, 25 experts in Taiwan’s aesthetic medical field (HCPs) participated in the event. Participants toured the production facilities of Hugel’s botulinum toxin ‘Letybo’ and hyaluronic acid (HA) filler ‘The Chaum’ (locally branded as ‘Revolex’) and checked the production systems and quality management capabilities in line with global standards.


They also visited domestic clinics to share the latest trends in the Korean aesthetic market, corresponding treatment know-how, and clinical cases. Dr. Seungju Lee, Director of DIADER Dermatology Clinic, conducted a live demonstration using Hugel’s toxin and fillers, providing practical, hands-on training directly applicable to real clinical settings.


Taiwan is one of the major aesthetic markets in the Asia-Pacific region, where procedures such as toxin, fillers, and skin boosters are widely popular. Hugel became the first Korean company to enter Taiwan in 2019, establishing a direct sales network centered on its local subsidiary. Currently, with a market share of around 30%, Hugel ranks second in the Taiwanese toxin market.


Hugel plans to increase its toxin market share to 35% by 2027, while gradually expanding its HA filler lineup, which launched formal sales last year, to create synergy with toxin sales and further strengthen its position in the Taiwanese aesthetic market.



Ji Seungwook, Executive Vice President overseeing business at Hugel, stated, “We organized this event to strengthen networking with medical professionals in Taiwan, one of Asia’s key aesthetic markets, and to give them firsthand experience of Hugel’s product competitiveness. Going forward, we will strive not only to expand our share of the toxin market but also to reinforce the competitiveness of our entire portfolio, including HA fillers and cosmetics.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing